Sean E. Aeder

Array ( [id] => 6634022 [patent_doc_number] => 20030211521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Breast cancer antigen' [patent_app_type] => new [patent_app_number] => 10/334726 [patent_app_country] => US [patent_app_date] => 2003-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 29811 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 52 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211521.pdf [firstpage_image] =>[orig_patent_app_number] => 10334726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801590 [patent_doc_number] => 20030096755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Suppression of inhibitors' [patent_app_type] => new [patent_app_number] => 10/336513 [patent_app_country] => US [patent_app_date] => 2003-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19282 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096755.pdf [firstpage_image] =>[orig_patent_app_number] => 10336513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304133 [patent_doc_number] => 20040115656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Treating breast cancer' [patent_app_type] => new [patent_app_number] => 10/320203 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7714 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115656.pdf [firstpage_image] =>[orig_patent_app_number] => 10320203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760766 [patent_doc_number] => 20030124127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Targeting leukemia cells' [patent_app_type] => new [patent_app_number] => 10/313250 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6575 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124127.pdf [firstpage_image] =>[orig_patent_app_number] => 10313250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860688 [patent_doc_number] => 07371834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Apoptosis-inducing factor' [patent_app_type] => utility [patent_app_number] => 10/308936 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30628 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371834.pdf [firstpage_image] =>[orig_patent_app_number] => 10308936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697257 [patent_doc_number] => 20030109451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Human arsenite-resistance protein' [patent_app_type] => new [patent_app_number] => 10/309379 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21326 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109451.pdf [firstpage_image] =>[orig_patent_app_number] => 10309379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034524 [patent_doc_number] => 20050033034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'ANTI-T CELL IMMUNOTOXIN FUSION PROTEIN AND ITS THERAPEUTIC USE' [patent_app_type] => utility [patent_app_number] => 10/496179 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6407 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20050033034.pdf [firstpage_image] =>[orig_patent_app_number] => 10496179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386563 [patent_doc_number] => 20040029795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer' [patent_app_type] => new [patent_app_number] => 10/306631 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 128658 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10306631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7380377 [patent_doc_number] => 20040081686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Use of particle vectors in immunomodulation' [patent_app_type] => new [patent_app_number] => 10/281371 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10856 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081686.pdf [firstpage_image] =>[orig_patent_app_number] => 10281371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 716425 [patent_doc_number] => 07053202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 10/272899 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23623 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053202.pdf [firstpage_image] =>[orig_patent_app_number] => 10272899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912244 [patent_doc_number] => 20050176002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Methods for detecting ovarian cancer' [patent_app_type] => utility [patent_app_number] => 10/492740 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19690 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176002.pdf [firstpage_image] =>[orig_patent_app_number] => 10492740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696850 [patent_doc_number] => 20030109044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Methods of using 279, a human G protein-coupled protein receptor' [patent_app_type] => new [patent_app_number] => 10/267811 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 50597 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109044.pdf [firstpage_image] =>[orig_patent_app_number] => 10267811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7280724 [patent_doc_number] => 20040063101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Human sarcoma-associated antigens' [patent_app_type] => new [patent_app_number] => 10/260708 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28133 [patent_no_of_claims] => 157 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063101.pdf [firstpage_image] =>[orig_patent_app_number] => 10260708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720778 [patent_doc_number] => 20060073553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 10/243298 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 116 [patent_figures_cnt] => 116 [patent_no_of_words] => 32215 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10243298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720376 [patent_doc_number] => 20060073150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer' [patent_app_type] => utility [patent_app_number] => 10/236878 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 100846 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073150.pdf [firstpage_image] =>[orig_patent_app_number] => 10236878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740740 [patent_doc_number] => 20030158109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Metastatic breast and colon cancer regulated genes' [patent_app_type] => new [patent_app_number] => 10/236006 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17764 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158109.pdf [firstpage_image] =>[orig_patent_app_number] => 10236006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211354 [patent_doc_number] => 07622260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Diagnostic and prognostic tests' [patent_app_type] => utility [patent_app_number] => 10/236031 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 37981 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 408 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622260.pdf [firstpage_image] =>[orig_patent_app_number] => 10236031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6791597 [patent_doc_number] => 20030086941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors' [patent_app_type] => new [patent_app_number] => 10/235236 [patent_app_country] => US [patent_app_date] => 2002-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 11176 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086941.pdf [firstpage_image] =>[orig_patent_app_number] => 10235236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675733 [patent_doc_number] => 20040126385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Methods and compositions for screening, diagnosing, or treating NF-kappaB related disease' [patent_app_type] => new [patent_app_number] => 10/229302 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12398 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126385.pdf [firstpage_image] =>[orig_patent_app_number] => 10229302 [rel_patent_id] =>[rel_patent_doc_number] =>)